Yael Mossé Laboratory News Updates
1 - 5 of 5
Children’s Hospital of Philadelphia Announces Endowed Chair in Pediatric Neuroblastoma Research
Published on in CHOP News
CHOP recipient, physician-scientist Dr. Yael Mossé, is innovating targeted, less toxic therapies for cancer affecting mostly infants and young children.
Advances in Pediatric Cancer Care
Published on in CHOP News
In a special airing on CBS Sunday Morning, Dr. Adamson details new therapies that are helping more children be cured.
New Drug May Overcome Treatment Resistance in a High-risk Children’s Cancer
Published on in CHOP News
CHOP researchers have identified a powerful new drug with “unparalleled” strength against refractory types of neuroblastoma.
CHOP Is a Founding Member of New NIH-Funded Research Consortium to Test New Cancer Treatments for Children
Published on in CHOP News
Building on its decades-long investigations in the biology and treatment of neuroblastoma, CHOP will lead the consortium’s neuroblastoma research program.
Classification of Gene Mutations in a Children’s Cancer May Point to Improved Treatments
Published on in CHOP News
CHOP and Penn Medicine experts are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations, setting the stage for a phase 3 clinical trial.